Blend Labs (BLND) insider lines up August stock sale

Rhea-AI Filing Summary

Blend Labs, Inc. insider Oxana Tkach filed a notice to sell shares of Blend Labs, Inc. common stock under Rule 144. The notice lists 30,686 shares of common stock to be sold through Charles Schwab & Co., Inc., with 233,256,934 shares of the same class outstanding. The planned sale date is August 17, 2026. The filing also notes that the securities derive from a restricted stock lapse on May 20, 2026, treated as equity compensation. In the prior three months, a separate sale of 5,625 shares of Blend Labs, Inc. common stock for total proceeds of $8,831.00 on May 22, 2026 is reported.

Key Figures

Shares to be sold: 30,686 shares Shares outstanding: 233,256,934 shares Planned sale date: 08/17/2026 +3 more

6 metrics

Shares to be sold 30,686 shares Planned sale of Blend Labs, Inc. common stock under Rule 144

Shares outstanding 233,256,934 shares Outstanding Blend Labs, Inc. common stock of the same class as of the notice

Planned sale date 08/17/2026 Expected date for Rule 144 sale of 30,686 shares

Prior 3‑month sale shares 5,625 shares Common stock sold on 05/22/2026 within the past three months

Prior 3‑month sale proceeds $8,831.00 Total consideration for 5,625 shares sold on 05/22/2026

Restricted stock lapse date 05/20/2026 Date restricted stock lapsed, classified as equity compensation

Key Terms

Rule 144, restricted stock lapse, equity compensation, common stock, +1 more

5 terms

Rule 144 regulatory

"insider Oxana Tkach filed a notice to sell shares under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock lapse financial

"The filing also notes that the securities derive from a restricted stock lapse"

equity compensation financial

"treated as equity compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

common stock financial

"sale of Blend Labs, Inc. common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

shares outstanding financial

"with 233,256,934 shares of the same class outstanding"

Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.

FAQ

What does Blend Labs (BLND) report in this Form 144 filing?

The filing reports a planned sale of 30,686 shares of Blend Labs, Inc. common stock by insider Oxana Tkach under Rule 144, with the sale expected to occur on August 17, 2026 through Charles Schwab & Co., Inc.

How many Blend Labs (BLND) shares are outstanding for this class?

The filing states that there are 233,256,934 shares of Blend Labs, Inc. common stock outstanding for the same class of securities as those covered by the 30,686-share planned sale under Rule 144.

What prior Blend Labs (BLND) share sales are disclosed in the last three months?

The document reports a prior transaction on May 22, 2026 involving the sale of 5,625 shares of Blend Labs, Inc. common stock, for total proceeds of $8,831.00, within the three months preceding the new planned sale.

What is the source of the Blend Labs (BLND) shares being sold under this Form 144?

The shares relate to a restricted stock lapse on May 20, 2026, categorized as equity compensation. This indicates the securities originated from compensation awards that became unrestricted before the planned Rule 144 sale.

Through which broker will the Blend Labs (BLND) Rule 144 sale be executed?

The notice identifies Charles Schwab & Co., Inc., located at 3000 Schwab Way, Westlake, TX 76262, as the broker handling the planned sale of 30,686 Blend Labs, Inc. common shares on or about August 17, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:53 PM Accepted by SEC EDGAR 08/17/2026 - 04:52 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	21209	30686.00	233256934	08/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/20/2026	Restricted Stock Lapse	BLEND LABS, INC.			21209	05/20/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
OXANA TKACH 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	05/22/2026	5625	8831.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)